Future directions in antimicrobial chemotherapy-Reference-Cited by-同舟云学术

Future directions in antimicrobial chemotherapy

Published:1992-08 Issue:4 Volume:14 Page:229-244
ISSN:0167-6555
Container-title:Pharmaceutisch Weekblad Scientific Edition
language:en
Short-container-title:Pharmaceutisch Weekblad Scientific Edition

Author:

Janknegt R.

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science,Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/BF01962545.pdf

Reference168 articles.

1. Bauernfeind A. Comparative antimicrobial spectrum and activity of ceftibuten against clinical isolates from West-Germany. Diagn Microbiol Infect Dis 1991;14:63–74.

2. Verbist L, Jacobs J, Hens K. Comparative antimicrobial activity of ceftibuten against multiple-resistant micro-organisms from Belgium. Diagn Microbiol Infect Dis 1991;14:55–61.

3. Wise R, Andrews JM, Ashby JP, Thornber D. Ceftibuten. A new orally absorbed cephalosporin. Diagn Microbiol Infect Dis 1991;14:45–52.

4. Cullmann W, Dick W, Stieglitz M, Opferkuch W. Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant Gram-positive and Gram-negative rods. Chemotherapy 1988;34:202–15.

5. Janknegt R. Cefixim. Therapeutische mogelijkheden van het eerste orale derde generatie cefalosporine [Therapeutic possibilities of the first oral thirdgeneration cephalosporine]. TGO 1991;16:85–90.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Piperacillin‐Tazobactam: A New β‐Lactam‐β‐Lactamase Inhibitor Combination;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;1996-03-04